Skip to main content

Table 2 Comparison of characteristics and laboratory data at recurrence between the EP and Non-EP groups

From: Pulmonary eosinophilia may indicate onset stage of allergic bronchopulmonary aspergillosis

Characteristic

EP group (n  =  6)

Non-EP group (n  =  19)

 

Recurrence

4 (67%)

15 (78%)

ns

Therapy

 Oral corticosteroids

5 (83%)

13/19 (68%)

ns

 Anti-fungal drugs

1 (17%)

16/19 (84%)

0.0055

Duration (months) before recurrence, median (IQR)

22.5 (20.5–22.9)

20.5 (13.8–34.8)

ns

Total follow-up period (years), median (IQR)

4.0 (2.6–7.7)

4.6 (3.1–8.3)

ns

Recurrence rate/y, median (IQR)

0.23 (0.10–0.41)

0.38 (0.14–0.67)

ns

Phenotype at recurrence

EP: 4/4 (100%)

Non-EP: 16/16 (100%)

0.0002

  1. Data are expressed as median and interquartile range (IQR) and categorical data are presented as number and percentage
  2. ns not significant